How does genomic research contribute to cancer R&D?
Genomic research has revolutionized cancer R&D by identifying specific genetic mutations that contribute to cancer development. This knowledge allows for the development of targeted therapies that can directly inhibit these mutations. For instance, the discovery of the BRCA1 and BRCA2 genes has led to improved screening and preventive strategies for breast and ovarian cancers.
